CiVi Biopharma
MD - Chevy ChasePharmaceutical
Focus: CiVi Biopharma is an early-stage biopharma company focused on novel therapies for cardiometabolic diseases, based in Chevy Chase, MD. Founded in 2020, the company is in active clinical development with a small pipeline in early phases.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Open Jobs
0
About CiVi Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow CiVi Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from CiVi Biopharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CiVi007
HypercholesterolemiaClinical Trials (1)
NCT03427710A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level
Phase 1Help build intelligence for CiVi Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.